Remove Access Remove DEA Remove State Laws
article thumbnail

DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

NORML

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 187
article thumbnail

Is The DEA Poised To Regulate Telepharmacy?

Cannabis Law Report

On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.

DEA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cato Institute “Cannabis Banking: A Clash Between Federal and State Laws”

Cannabis Law Report

Despite progress over the past decade, the cannabis industry still struggles to access a fundamental piece of the U.S. Although 18 states have fully legalized, cannabis is still a sticky issue for banks and other financial institutions because it remains illegal at the federal level. economy: the financial system.

Banking 52
article thumbnail

Constitutionality of Cannabis: Federal Lawsuit Against DEA, DOJ Proceeds

Marijuana Lawyer Blog

Defendants are acting-Attorney General Matthew Whitaker, the acting director of the DEA and the federal government. The Los Angeles CANNABIS LAW Group represents growers, dispensaries, collectives, patients and those facing marijuana charges. Additional Resources: Appeal Hearing in Cannabis Lawsuit Against the DEA , Dec.

DEA 40
article thumbnail

The Ketamine Clinic Craze: Legalities and Possibilities

Canna Law Blog

The FDA doesn’t have any regulations on point for the control and oversight of ketamine clinics when it comes to infusion therapy and the states don’t really either. Failure to follow these very specific legal directives can lead to immediate criminal liability under federal law.

Therapy 91
article thumbnail

Emerge Law Group (OR): PSILOCYBIN THERAPY FOR PATIENTS WITH ADVANCED ILLNESS IN OREGON

Cannabis Law Report

Accordingly, it cannot be prescribed by a physician and it is not legally accessible to those who might benefit from it as a therapeutic treatment. Access Pursuant to the Oregon Psilocybin Services Act. Access to Psilocybin Therapy Pursuant to Right to Try Laws. Source: [link].

Therapy 52
article thumbnail

Update on Cannabis Administration and Opportunity Act

Cannabis Law Report

Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Bureau of Alcohol Tobacco Firearms and Explosives (ATF). Decriminalization of Cannabis, Recognition of State law Controlling Cannabis. It would transfer primary agency jurisdiction over cannabis from the DEA to the FDA, TTB, and ATF.